In this episode of The Benzodiazepine Podcast, host Mark Leeds, D.O., engages in a comprehensive discussion with Dr. Ladan Eshkevari, PhD, CRNA, LAc, FAAN, from Avesta Ketamine Wellness. Though the primary focus of the dialogue is not centered on benzodiazepine protracted withdrawal or benzodiazepine-induced neurological dysfunction (BIND), the discussion about brain healing and ketamine's action at NMDA receptors is profoundly relevant. There is a particularly interesting section where Dr. Eshkevari discusses how the neurotransmitter, glutamate, responds to being blocked at the NMDA receptor by ketamine, and how the neurotransmitter, GABA, is also affected.

For many grappling with long-term benzodiazepine syndromes, understanding potential treatments becomes paramount. Symptoms such as akathisia, histamine sensitivity/MCAS, anxiety, insomnia, the unsettling 'benzo belly', and experiences of depersonalization/derealization, underline the urgency in uncovering solutions to alleviate benzo withdrawal symptoms.

Dr. Eshkevari will elucidate the complexities of ketamine therapy and its potential in the broader scope of neurological healing. Further, we will delve into the intriguing synergy between acupuncture and ketamine therapy, exploring concepts like chi from traditional Chinese medicine and the potential enhancement of ketamine treatment through specific acupuncture points.

Listeners, especially those affected by benzodiazepine-related disorders, are urged to immerse themselves in this episode. The exploration promises insights into therapeutic avenues that might play a pivotal role in managing and potentially ameliorating the symptoms associated with benzodiazepine withdrawal.

Please visit Dr. Eshkevari at https://avestaketaminewellness.com/.

Also, if you find this material interesting and helpful, please visit our podcast website and practice website here:

https://drleeds.com and https://therehab.com.